Limits...
J Young Pharm. 2011: What are we aiming at?

Mueen AK - J Young Pharm (2011)

View Article: PubMed Central - PubMed

Affiliation: Editor-in-Chief, J Young Pharm. mueen.ahmed@gmail.com.

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

A journal is always judged based on the quality of papers, such as original papers, reviews, editorials, letters to the editor, being published and these articles play a most crucial role in research process... Currently, in most countries, academic promotion of an individual, recruitment, and distribution of financial sources for research are all subjected to the evaluation of a researcher/institution profile in world renowned indexing systems and catalogues, such as PubMed, Scopus, Index Copernicus, Institute for Scientific Information (ISI), etc... J Young Pharm. is also expecting SJR Ranking by the end of this year as we are already in SCOPUS... Figure 1 and Table 1 show the rate of acceptance/rejection rate for the past 2 years; we have drastically improved the refining of papers in the last year, as it can be seen, our rejection rate is higher when compared to the year 2009... Combined efforts of authors, reviewers, editorial board members, and of course, publisher will further improve the quality of papers being submitted and published... On behalf of the editorial board members, I would like to thank all the reviewers who have helped us in refining the papers submitted to J Young Pharm... We are presenting a brief report on the performance of J Young Pharm during the year 2010 [Figure 2]... Performance of our reviewers is included in Table 2 and summary of JYP results for the year 2010 is presented in Table 3... Mentoring authors from around the world... Learning a novel and effective approach to reviewing scholarly papers... This policy will remain throughout the year until next notification... I would like to list all the most cited papers from the year 2009... I encourage the authors to cite J Young Pharm. papers and utilize them in their research writings.

No MeSH data available.


Acceptance and rejection rate of J Young Pharm. during the past 2 years (Courtesy: journalonweb)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3094554&req=5

Figure 0001: Acceptance and rejection rate of J Young Pharm. during the past 2 years (Courtesy: journalonweb)

Mentions: To achieve leading positions in academics and scientific field, academic and research institutions worldwide are now strongly encouraged to improve the quality of research studies and to publish papers in peer-reviewed journals visible in most prestigious indexing databases.[3] J Young Pharm. is now indexed with Caspur, Chemical Abstracts, DOAJ, EBSCO Publishing’s Electronic Databases, Expanded Academic ASAP, Genamics JournalSeek, Global Health, Google Scholar, Health and Wellness Research Center, Health Reference Center Academic, Hinari, Index Copernicus, OpenJGate, PrimoCentral, ProQuest, PubMed, Pubmed Central, SCOLOAR, SCOPUS, SIIC databases, Summon by Serial Solutions, and Ulrich’s International Periodical Directory. We are aiming at inclusion in Institution of Scientific Information (ISI) during this year. J Young Pharm. is also expecting SJR Ranking by the end of this year as we are already in SCOPUS.Figure 1 and Table 1 show the rate of acceptance/rejection rate for the past 2 years; we have drastically improved the refining of papers in the last year, as it can be seen, our rejection rate is higher when compared to the year 2009. Combined efforts of authors, reviewers, editorial board members, and of course, publisher will further improve the quality of papers being submitted and published.


J Young Pharm. 2011: What are we aiming at?

Mueen AK - J Young Pharm (2011)

Acceptance and rejection rate of J Young Pharm. during the past 2 years (Courtesy: journalonweb)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3094554&req=5

Figure 0001: Acceptance and rejection rate of J Young Pharm. during the past 2 years (Courtesy: journalonweb)
Mentions: To achieve leading positions in academics and scientific field, academic and research institutions worldwide are now strongly encouraged to improve the quality of research studies and to publish papers in peer-reviewed journals visible in most prestigious indexing databases.[3] J Young Pharm. is now indexed with Caspur, Chemical Abstracts, DOAJ, EBSCO Publishing’s Electronic Databases, Expanded Academic ASAP, Genamics JournalSeek, Global Health, Google Scholar, Health and Wellness Research Center, Health Reference Center Academic, Hinari, Index Copernicus, OpenJGate, PrimoCentral, ProQuest, PubMed, Pubmed Central, SCOLOAR, SCOPUS, SIIC databases, Summon by Serial Solutions, and Ulrich’s International Periodical Directory. We are aiming at inclusion in Institution of Scientific Information (ISI) during this year. J Young Pharm. is also expecting SJR Ranking by the end of this year as we are already in SCOPUS.Figure 1 and Table 1 show the rate of acceptance/rejection rate for the past 2 years; we have drastically improved the refining of papers in the last year, as it can be seen, our rejection rate is higher when compared to the year 2009. Combined efforts of authors, reviewers, editorial board members, and of course, publisher will further improve the quality of papers being submitted and published.

View Article: PubMed Central - PubMed

Affiliation: Editor-in-Chief, J Young Pharm. mueen.ahmed@gmail.com.

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

A journal is always judged based on the quality of papers, such as original papers, reviews, editorials, letters to the editor, being published and these articles play a most crucial role in research process... Currently, in most countries, academic promotion of an individual, recruitment, and distribution of financial sources for research are all subjected to the evaluation of a researcher/institution profile in world renowned indexing systems and catalogues, such as PubMed, Scopus, Index Copernicus, Institute for Scientific Information (ISI), etc... J Young Pharm. is also expecting SJR Ranking by the end of this year as we are already in SCOPUS... Figure 1 and Table 1 show the rate of acceptance/rejection rate for the past 2 years; we have drastically improved the refining of papers in the last year, as it can be seen, our rejection rate is higher when compared to the year 2009... Combined efforts of authors, reviewers, editorial board members, and of course, publisher will further improve the quality of papers being submitted and published... On behalf of the editorial board members, I would like to thank all the reviewers who have helped us in refining the papers submitted to J Young Pharm... We are presenting a brief report on the performance of J Young Pharm during the year 2010 [Figure 2]... Performance of our reviewers is included in Table 2 and summary of JYP results for the year 2010 is presented in Table 3... Mentoring authors from around the world... Learning a novel and effective approach to reviewing scholarly papers... This policy will remain throughout the year until next notification... I would like to list all the most cited papers from the year 2009... I encourage the authors to cite J Young Pharm. papers and utilize them in their research writings.

No MeSH data available.